Regadenoson - NDC Database

14 records found

Page:1

0409-1401 Mar 01, 2023
Regadenoson .08 mg/ml Intravenous Injection, Solution by Hospira, Inc.

0641-6253 Apr 03, 2023
Regadenoson .08 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.

16729-477 Mar 10, 2023
Regadenoson .08 mg/ml Intravenous Injection, Solution by Accord Healthcare Inc.

36000-364 May 23, 2023
Regadenoson .08 mg/ml Intravenous Injection, Solution by Baxter Healthcare Corporation

43598-616 Apr 23, 2023
Regadenoson .08 mg/ml Intravenous Injection by Dr. Reddy's Laboratories Inc.

51662-1448 Dec 10, 2019
Lexiscan(r) (Regadenoson) .08 mg/ml Intravenous Injection, Solution by Hf Acquisition Co LLC, Dba Healthfirst

55150-443 Oct 26, 2022
Regadenoson .08 mg/ml Intravenous Injection by Eugia Us LLC

60505-6116 Mar 10, 2023
Regadenoson .08 mg/ml Intravenous Injection, Solution by Apotex Corp.

67457-994 Sep 21, 2023
Regadenoson .4 mg/5ml Intravenous Injection by Mylan Institutional LLC

68083-175 Jul 12, 2022
Regadenoson .08 mg/ml Intravenous Injection, Solution by Gland Pharma Limited

71288-201 Apr 11, 2022
Regadenoson .08 mg/ml Intravenous Injection, Solution by Meitheal Pharmaceuticals Inc.

72611-874 Jul 03, 2023
Regadenoson .08 mg/ml Intravenous Injection, Solution by Almaject, Inc.

76329-3321 Apr 20, 2023
Regadenoson .08 mg/ml Intravenous Injection, Solution by International Medication Systems, Limited

83032-001 Aug 22, 2024
Regadenoson .08 mg/ml Intravenous Injection, Solution by Indies Pharma Jamaica Limited

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.